These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29147840)

  • 1. Medulloblastoma in adults : A retrospective single institution analysis.
    Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
    Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
    Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
    Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
    Saraf A; Yock TI; Niemierko A; Oh KS; Curry WT; Butler WE; Forst DA; Arrillaga-Romany I; Ebb DH; Tarbell NJ; MacDonald S; Loeffler JS; Shih HA
    Neuro Oncol; 2022 Dec; 24(12):2180-2189. PubMed ID: 35671386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.
    von Bueren AO; Friedrich C; von Hoff K; Kwiecien R; Müller K; Pietsch T; Warmuth-Metz M; Hau P; Benesch M; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2015 Nov; 51(16):2434-43. PubMed ID: 26254812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors of radiation therapy for medulloblastoma.
    Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).
    Esbah O; Demirci U; Dane F; Gunaydsin Y; Ozdemir N; Siyar Ekinci A; Kodaz H; Yazilitas D; Rzayev R; Guney Y; Seker M; Uysal M; Inal A; Bilici A; Benekli M; Oksuzoglu B; Buyukberber S
    J BUON; 2016; 21(2):456-60. PubMed ID: 27273958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
    Beier D; Proescholdt M; Reinert C; Pietsch T; Jones DTW; Pfister SM; Hattingen E; Seidel C; Dirven L; Luerding R; Reijneveld J; Warmuth-Metz M; Bonsanto M; Bremer M; Combs SE; Rieken S; Herrlinger U; Kuntze H; Mayer-Steinacker R; Moskopp D; Schneider T; Beringer A; Schlegel U; Stummer W; Welker H; Weyerbrock A; Paulsen F; Rutkowski S; Weller M; Wick W; Kortmann RD; Bogdahn U; Hau P
    Neuro Oncol; 2018 Feb; 20(3):400-410. PubMed ID: 29016837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of medulloblastoma in adults.
    Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
    Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
    Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
    Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
    Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
    J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
    Haque W; Verma V; Brian Butler E; Teh BS
    J Clin Neurosci; 2020 Jun; 76():154-160. PubMed ID: 32291240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.